GSMA Postpones Mobile 360 – Europe Event
The GSMA announced today that, due to the ongoing security situation in Brussels following the attacks in France, the Mobile 360 – Europe conference scheduled to take place on Thursday, 3 December in Brussels, will be postponed to a later date.
Whilst there have been no direct threats to the event, the restrictions on travel would make it extremely difficult for attendees, speakers and members to travel to and within Brussels.
The GSMA remains committed to the Mobile 360 – Europe event and is currently working with all stakeholders to determine a new date to host the event in 2016. Updated event details will be made available as soon as planning has been finalised.
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 250 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai and the Mobile 360 Series conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
SHELL/BIO-BEAN20.11.2017 01:03 | pressemeddelelse
Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses
SAMSUNG-BIOEPIS19.11.2017 23:23 | pressemeddelelse
Samsung Bioepis Receives Regulatory Approval for Europe's First Trastuzumab Biosimilar, ONTRUZANT®
FOCP19.11.2017 17:33 | pressemeddelelse
Cancer Patients, Survivors, Supporters and Caregivers Undertake UAE's First Relay for Life
ASTRAZENECA19.11.2017 00:02 | pressemeddelelse
New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases
ASTRAZENECA18.11.2017 19:22 | pressemeddelelse
New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer
CHINA-HI-TECH-FAIR18.11.2017 10:13 | pressemeddelelse
Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum